Prescription Drug Costs Among People With Alzheimer Disease and Related Dementias

Seyeon Jang; Rozalina G McCoy; Jie Chen

doi:10.1001/jamanetworkopen.2024.33026

Prescription Drug Costs Among People With Alzheimer Disease and Related Dementias

JAMA Netw Open. 2024 Sep 3;7(9):e2433026. doi: 10.1001/jamanetworkopen.2024.33026.

Authors

Seyeon Jang^{1

2

3}, Rozalina G McCoy^{1

2

4

5}, Jie Chen^{1

2

3

4}

Affiliations

¹ Department of Health Policy and Management, School of Public Health, University of Maryland, College Park.
² University of Maryland Center on Aging, College Park.
³ The Hospital and Public Health Interdisciplinary Research Lab, School of Public Health, University of Maryland, College Park.
⁴ University of Maryland Institute for Health Computing, Bethesda.
⁵ Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore.

No abstract available

Plain language summary

This cross-sectional study examines the association of Alzheimer disease and related dementias with prescription drug expenditures across cost distributions.

MeSH terms

Aged
Aged, 80 and over
Alzheimer Disease* / economics
Cross-Sectional Studies
Dementia* / economics
Drug Costs* / statistics & numerical data
Female
Humans
Male
Prescription Drugs* / economics
United States

Substances

Prescription Drugs